Investing.com - Senti Biosciences reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Senti Biosciences announced earnings per share of $-0.380 on revenue of $1.77M. Analysts polled by Investing.com EPS of $-0.415 on revenue of $500K.
Senti Biosciences 's are down 4.96% and is trading at $2.480 , still down 76.04% from its 52 week high of $10.35 set on Tuesday, December 7, 2021.
Senti Biosciences shares gained 8.30% to trade at $2.480 in intra-day trade the report.
Senti Biosciences follows other major Healthcare sector earnings this month
Senti Biosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar